ULBI Ultralife Corp: Company Value to Revenue Ratio

Ultralife Corp (ULBI) - corporate logo

High regulatory barriers and defense patents provide Ultralife Corporation (ULBI) with long-term resilience. The EV/Sales ratio confirms this stability, reaching 1593.89. The business foundation is based on the development of high-energy lithium systems for extreme environments. Manufacturing capacities in the US and UK rely on long-term contracts with the medical and military sectors.

ULBI (Ultralife Corp.) Company Value to Revenue history from 11/23/2025 to 11/20/2026

Financial and market metric breakdowns for Ultralife (ULBI)

- cash and cash flow indicators:
Initial company analysis:Ultralife Corporation ULBI
Flagship merchandise of ultralifecorporation.com

This indicator compares the total enterprise value to operating revenues, excluding the impact of debt load. The metric determines the market price per unit of revenue, allowing for an assessment of asset monetization efficiency. For Ultralife Corporation (ULBI), this parameter reflects the dependence of capitalization on US and NATO defense orders. Geopolitical instability stimulates demand, influencing the dynamics of the EV/Sales multiple. Analyzing this chart helps identify whether the business is overvalued or experiencing a systemic decline.